Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109776384B reveals a one-step Rh-catalyzed synthesis of complex bis-quaternary carbon oxindoles, offering significant cost reduction in API manufacturing and high atom economy.
Novel synthetic route for Cephanolide C via patent CN108129432B. Offers scalable manufacturing and cost reduction for pharmaceutical intermediates supply chains.
Novel patent CN117820194A details a palladium-free route for high-purity indole intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN117820194A offers palladium-free synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN100338039C details a novel Lewis acid-catalyzed synthesis for S/R-Ornidazole. This method ensures >99.5% purity, offering significant cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN105368913A reveals dual-enzyme immobilization for chiral amino acids. Offers high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN105368913A reveals dual-enzyme immobilization for high-purity chiral unnatural amino acid production with significant cost and supply chain advantages.
Patent CN1053431A reveals an advanced method for Fosinopril synthesis, offering improved stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Advanced Fmoc solid-phase synthesis for Triptorelin bulk drug. Patent CN103012565A offers high yield, low racemization, and scalable manufacturing for reliable supply chains.
Patent CN113698458A details a full liquid-phase method for triptorelin, offering high purity crude product and significant cost reduction in peptide manufacturing compared to solid-phase routes.
Novel purification method for Iopromide using diacetoxy intermediate removes byproducts efficiently, ensuring high yield and pharmaceutical grade purity for contrast agents.
Patent CN102190709A details a novel two-fragment solid-phase synthesis for LH-RH derivatives, offering high purity and cost-effective manufacturing solutions.
Patent CN102827030A details a safe, high-yield route for (3R,5R)-3,5-dihydroxy-6-cyanohexanoate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN107082774A details novel 1,2,4-triazole indole derivatives with anti-tumor activity. Streamlined synthesis offers cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN107082774A reveals efficient tubulin inhibitor synthesis. Low cost, scalable route for high-purity pharmaceutical intermediates supply.
Analyzing patent CN113004245A for a mild, high-yield desloratadine preparation method offering significant cost reduction and improved purity for pharmaceutical manufacturing.
Patent CN112028947B reveals a novel alkaline synthesis for Tribenoside, eliminating genotoxic impurities and ensuring high purity for reliable pharmaceutical intermediate supply chains.
Novel one-pot acid hydrolysis route for phloroglucinol ensures high purity and scalable production for global pharmaceutical intermediate supply chains.
Patent CN120659800A details high-purity tetrapeptide synthesis reducing D-isomer impurities for scalable API manufacturing and cost-effective supply chains.
Novel Boc-protected route for Nifuratel avoids toxic methyl mercaptan, offering high purity and scalable manufacturing for pharmaceutical intermediates.